Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Human Mesenchymal Stem Cell (hMSC) Infusion for Anti-Aging and REGENerative Therapy

Authors not listed

Landmark Medical Centre Sdn Bhd · 2020

Abstract

To evaluate the safety and efficacy of human Mesenchymal Stem Cell (hMSC) infusion therapy, in preserving general wellness and ameliorating or reversing the effects of aging in our study population

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-23 MST

Cite this

APA
Anonymous. (2020). Human Mesenchymal Stem Cell (hMSC) Infusion for Anti-Aging and REGENerative Therapy. <em>Landmark Medical Centre Sdn Bhd</em>. https://clinicaltrials.gov/study/NCT04174898
Vancouver
Anonymous. Human Mesenchymal Stem Cell (hMSC) Infusion for Anti-Aging and REGENerative Therapy. Landmark Medical Centre Sdn Bhd. 2020.
BibTeX
@misc{anon2020HumanM, title = {Human Mesenchymal Stem Cell (hMSC) Infusion for Anti-Aging and REGENerative Therapy}, author = {Anonymous}, journal = {Landmark Medical Centre Sdn Bhd}, year = {2020}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings